Apex Capital Management’s Pfizer PFE Stock Holding History

Apex Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$332K	Sell	11,814 -501	-4%	-$14.3K	0.01%	253
2015 Q4	$377K	Sell	12,315 -102,757	-89%	-$3.23M	0.01%	227
2015 Q3	$3.43M	Sell	115,072 -235	-0.2%	-$7.54K	0.08%	165
2015 Q2	$3.67M	Sell	115,307 -20,797	-15%	-$678K	0.08%	166
2015 Q1	$4.49M	Sell	136,104 -10,350	-7%	-$329K	0.11%	153
2014 Q4	$4.33M	Sell	146,454 -506	-0.3%	-$14.5K	0.12%	151
2014 Q3	$4.12M	Buy	146,960 +1,614	+1%	+$45.3K	0.12%	129
2014 Q2	$4.09M	Sell	145,346 -1,321	-0.9%	-$37.7K	0.13%	126
2014 Q1	$4.47M	Buy	146,667 +11,576	+9%	+$345K	0.16%	111
2013 Q4	$3.93M	Sell	135,091 -8,852	-6%	-$258K	0.15%	112
2013 Q3	$3.92M	Sell	143,943 -36,081	-20%	-$982K	0.17%	104
2013 Q2	$4.78M	Buy	+180,024	New	+$4.97M	0.23%	99

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Apex Capital Management's PFE Position: Q1 2016 in Review

Apex Capital Management reduced its Pfizer (PFE) stake by 4.1% in Q1 2016, selling an estimated $14.3K and leaving 11,814 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #253.

Apex Capital Management first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.78M in Q2 2013. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Apex Capital Management held 11,814 shares of Pfizer worth $332K as of Q1 2016.
Apex Capital Management sold 501 Pfizer shares in Q1 2016, an estimated $14.3K.
Pfizer made up 0.01% of Apex Capital Management's portfolio in Q1 2016, its #253 holding.
Apex Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
Apex Capital Management's Pfizer position peaked at $4.78M in Q2 2013.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.